Drug Delivery Systems for Metabolic Disorders
-
20% KEDVEZMÉNY?
- A kedvezmény csak az 'Értesítés a kedvenc témákról' hírlevelünk címzettjeinek rendeléseire érvényes.
- Kiadói listaár EUR 175.00
-
72 581 Ft (69 125 Ft + 5% áfa)
Az ár azért becsült, mert a rendelés pillanatában nem lehet pontosan tudni, hogy a beérkezéskor milyen lesz a forint árfolyama az adott termék eredeti devizájához képest. Ha a forint romlana, kissé többet, ha javulna, kissé kevesebbet kell majd fizetnie.
- Kedvezmény(ek) 20% (cc. 14 516 Ft off)
- Kedvezményes ár 58 065 Ft (55 300 Ft + 5% áfa)
Iratkozzon fel most és részesüljön kedvezőbb árainkból!
Feliratkozom
72 581 Ft
Beszerezhetőség
Megrendelésre a kiadó utánnyomja a könyvet. Rendelhető, de a szokásosnál kicsit lassabban érkezik meg.
Why don't you give exact delivery time?
A beszerzés időigényét az eddigi tapasztalatokra alapozva adjuk meg. Azért becsült, mert a terméket külföldről hozzuk be, így a kiadó kiszolgálásának pillanatnyi gyorsaságától is függ. A megadottnál gyorsabb és lassabb szállítás is elképzelhető, de mindent megteszünk, hogy Ön a lehető leghamarabb jusson hozzá a termékhez.
A termék adatai:
- Kiadó Elsevier Science
- Megjelenés dátuma 2022. augusztus 26.
- ISBN 9780323996167
- Kötéstípus Puhakötés
- Terjedelem526 oldal
- Méret 276x215 mm
- Súly 1310 g
- Nyelv angol 290
Kategóriák
Hosszú leírás:
Drug Delivery Systems for Metabolic Disorders presents the most recent developments on the targeted delivery of drugs to deal with metabolic disorders in a safe, compliant and continuous way. The book covers recent developments in advanced drug delivery systems in various metabolic disorders, including disturbances in protein, lipid, carbohydrate and hormone metabolism and lysosomal and mitochondrial disorders. It provides a brief introduction to metabolic disorders, along with a focus on the current landscape and trends in understanding disease pathology using different in vitro and in vivo models required for clinical applications and developments of new therapeutics.
Each subsequent chapter covers drug delivery systems dedicated to metabolic diseases caused by disturbances in protein, lipid, carbohydrate and hormone metabolism. Then, it moves on to cover lysosomal storage disorders and applications of phytopharmaceuticals in this context. This is the perfect reference for researchers in pharmaceutical science who are interested in developing new treatments for metabolic diseases.
TöbbTartalomjegyzék:
1. Introduction to metabolic disorders
2. Cellular and molecular mechanisms involved in metabolic disorders
3. Current practices in drug delivery for metabolic disorders
4. Recent developments towards treatment of amyloidosis.
5. Advanced drug delivery systems targeting to improve therapeutic outcomes in Porphyria
6. Advanced drug delivery systems targeting Kwashiorkor involving disturbance in protein metabo-lism
7. Advanced drug delivery systems targeting metabolic disorders involving a disturbance in protein metabolism:ï¿1⁄2 Erythropoietic Uroporphyria.
8. Combating Atherosclerosis with novel drug delivery approaches: From benchside to commerciali-zation
9. Advanced drug delivery systems in the management of Gaucher Disease
10. Advanced drug delivery systems focusing the metabolic disorders due to deregulation of lipid me-tabolism: Niemann Pick Disease & Letterer-Siwe disease
11. Novel Drug Delivery system to treat Niemann-Pick disease
12. Novel 3D printing drug delivery system for the prevention and treatment of Atherosclerosis
13. Advanced drug delivery systems to treat Huntington disease: Challenges and opportunities
14. Advanced Drug Delivery Systems for obesity
15. Advanced drug delivery systems probing the metabolic disorder due to deregulation in carbohy-drate metabolism
16. Advanced drug delivery systems dealing with metabolic disorder due to disturbance in hormone metabolism- hypoglycaemia and hyperglycemia,
17. EMERGING drugï¿1⁄2 delivery in the treatment of hyperpituitarism and hypopituitarism
18. Advanced drug deliver system dealing with metabolisn disorders due to disturbance in harmone metabolismï¿1⁄2 example Hypoparathyroidism and Hyperparathyroidism
19. An update on development of advanced drug delivery systems for treatment of hyperthyroidism
20. Advanced drug delivery systems involving lysosomal storage disorders for Schinder disease and other disorders
21. Advanced drug delivery systems involving lysosomal storage disorders for Fabry disease
22. Drug delivery systems in Krabbe Disease: Present and prospective approaches.
23. Advanced Treatment Strategies to combatï¿1⁄2 Tay-Sachs Disease (TSD)
24. Sandhoff Disease: Pathology and Advanced Treatment Strategies
25. Nanomaterial-based drug delivery approaches for metabolic disorders.
26. Eye in Metabolic Disorders: Manifestations and Drug Delivery Systems
27. Advanced drug delivery systems involving mitochondrial disorders
28. Application of phytoceuticals in targeting metabolic disorders
29. Phytonanoparticles towards the treatment of diabetes.
30. Role of Neutraceuticals in metabolic disorders
31. Latest Advances of phytomedicine in drug delivery systems for targeting metabolic disorders.
32. Clinical trials, future prospects and challenges of drug delivery in combating metabolic disorders
Nathan Boone and the American Frontier
14 516 Ft
13 355 Ft
